The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
Open accessAbstract
BACKGROUND: Currently, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) of less than 0.70 as assessed by spirometry after bronchodilator use. However, many smokers who do not meet this definition have respiratory symptoms. METHODS: We conducted an observational study involving 2736 current or former smokers and controls who had never smoked and measured their respiratory symptoms using the COPD Assessment Test (CAT; scores range from 0 to 40, with higher scores indicating greater severity of symptoms). We examined whether current or former smokers who had preserved pulmonary function as assessed by spirometry (FEV1:FVC ≥0.70 and an FVC above the lower limit of the normal range after bronchodilator use) and had symptoms (CAT score, ≥10) had a higher risk of respiratory exacerbations than current or former smokers with preserved pulmonary function who were asymptomatic (CAT score, <10) and whether those with symptoms had different findings from the asymptomatic group with respect to the 6-minute walk distance, lung function, or high-resolution computed tomographic (HRCT) scan of the chest. RESULTS: Respiratory symptoms were present in 50% of current or former smokers with preserved pulmonary function. The mean (±SD) rate of respiratory exacerbations among symptomatic current or former smokers was significantly higher than the rates among asymptomatic current or former smokers and among controls who never smoked (0.27±0.67 vs. 0.08±0.31 and 0.03±0.21 events, respectively, per year; P<0.001 for both comparisons). Symptomatic current or former smokers, regardless of history of asthma, also had greater limitation of activity, slightly lower FEV1, FVC, and inspiratory capacity, and greater airway-wall thickening without emphysema according to HRCT than did asymptomatic current or former smokers. Among symptomatic current or former smokers, 42% used bronchodilators and 23% used inhaled glucocorticoids. CONCLUSIONS: Although they do not meet the current criteria for COPD, symptomatic current or former smokers with preserved pulmonary function have exacerbations, activity limitation, and evidence of airway disease. They currently use a range of respiratory medications without any evidence base. (Funded by the National Heart, Lung, and Blood Institute and the Foundation for the National Institutes of Health; SPIROMICS ClinicalTrials.gov number, NCT01969344.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Spirometric Reference Values from a Sample of the General U.S. Population
HANKINSON, J. L., ODENCRANTZ, J. R., & FEDAN, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,206
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927 · cited 1×
“Nonwhite 62 (31) 93 (22) 177 (42) 45 (13) 113 (18)”
Semiparametric regression for the mean and rate functions of recurrent events
Lin, D. Y., Wei, L. J., Yang, I., & Ying, Z. (2000) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00259 · Cited by 969
Physiology of obesity and effects on lung function
Salome, C. M., King, G. G., & Berend, N. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00694.2009 · Cited by 831
Development, validity and responsiveness of the Clinical COPD Questionnaire.
van der Molen, T., Willemse, B. W. M., Schokker, S., ten Hacken, N. H. T., Postma, D. S., & Juniper, E. F. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-13 · Cited by 733
Clinical and Radiologic Disease in Smokers With Normal Spirometry
Regan, E. A., Lynch, D. A., Curran-Everett, D., Curtis, J. L., Austin, J. H. M., Grenier, P. A., Kauczor, H.-U., Bailey, W. C., DeMeo, D. L., Casaburi, R. H., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.2735 · Cited by 465
Self-citationObesity Is a Risk Factor for Dyspnea but Not for Airflow Obstruction
Sin, D. D., Jones, R. L., & Man, S. F. P. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.13.1477 · Cited by 418
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1
Couper, D., LaVange, L. M., Han, M., Barr, R. G., Bleecker, E., Hoffman, E. A., Kanner, R., Kleerup, E., Martinez, F. J., Woodruff, P. G., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203897 · Cited by 394
Self-citationPatel, B. D., Coxson, H. O., Pillai, S. G., Agustí, A. G. N., Calverley, P. M. A., Donner, C. F., Make, B. J., Müller, N. L., Rennard, S. I., Vestbo, J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-059oc · Cited by 326
Self-citationCelli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00009015 · Cited by 204
Self-citationCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Agusti, A., Edwards, L. D., Celli, B., MacNee, W., Calverley, P. M. A., Müllerova, H., Lomas, D. A., Wouters, E., Bakke, P., Rennard, S., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00195212 · Cited by 201
Self-citationDiagnosis and early detection of COPD using spirometry.
Johns, D. P., Walters, J. A., & Walters, E. H. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.08.18 · Cited by 169
Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agusti, A. A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Review · doi:10.1183/16000617.00000315 · Cited by 117
Self-citationAgustí, A. G. N., Hurd, S. S., Jones, P., Fabbri, L. M., Martínez, F. J., Vogelmeier, C. F., Vestbo, J., & Rodriguez‐Roisin, R. (2013) · European Respiratory Journal · doi:10.1183/09031936.00036513 · Cited by 112
Oelsner, E. C., Hoffman, E. A., Folsom, A. R., Carr, J. J., Enright, P., Kawut, S. M., Kronmal, R. A., Lederer, D. J., Lima, J. A. C., Lovasi, G. S., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2570 · Cited by 99
Self-citationExacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Beghé, B., Verduri, A., Roca, M., & Fabbri, L. M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00180812 · Cited by 97
Prediction of Acute Respiratory Disease in Current and Former Smokers With and Without COPD
Bowler, R. P., Kim, V., Regan, E. A., Williams, A., Santorico, S. A., Make, B. J., Lynch, D. A., Hokanson, J. E., Washko, G. R., Bercz, P. A., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2946 · Cited by 87
Self-citationTan, W. C., Bourbeau, J., Hernandez, P., Chapman, K. R., Cowie, R. L., FitzGerald, J. M., Marciniuk, D. D., Maltais, F., Buist, A. S., O’Donnell, D. E., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-205048 · Cited by 86
The clinical impact of non-obstructive chronic bronchitis in current and former smokers
Martinez, C. H., Kim, V., Chen, Y., Kazerooni, E. A., Murray, S., Criner, G. J., Curtis, J. L., Regan, E. A., Wan, E. S., Hersh, C. P., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.11.003 · Cited by 75
Self-citationLópez-Campos, J. L., & Agustí, A. G. N. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00242-8 · Cited by 53
Cited by
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Chronic obstructive pulmonary disease
Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00470-6 · Cited by 1,219
Self-citationChronic obstructive pulmonary disease
Rabe, K. F., & Watz, H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31222-9 · Cited by 960
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Respirology · doi:10.1111/resp.13012 · Cited by 681
Self-citation
Metadata
- Authors
- Woodruff, P. G., Barr, R. G., Bleecker, E., Christenson, S. A., Couper, D., Curtis, J. L., Gouskova, N. A., Hansel, N. N., Hoffman, E. A., Kanner, R. E., Kleerup, E., Lazarus, S. C., Martinez, F. J., Paine, R., Rennard, S., Tashkin, D. P., & Han, M. K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-05-12
- Volume
- 374
- Issue
- 19
- Pages
- 1811-1821
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2366256932
- Cited by
- 684
- References
- 25
- FWCI
- 74.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.